University of Massachusetts and BioVeris Join Forces to Find Chlamydia Vaccine
August 17, 2005
The University of Massachusetts and Gaithersburg, Md.-based BioVeris Corp. are cooperating in the search for a chlamydia vaccine. Under their agreement, BioVeris will provide up to $600,000 to aid research in exchange for exclusive patent rights on the vaccine. Researchers at the university have been pursuing a chlamydia vaccine for more than 20 years.
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.